David Neal Franz. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh： See more » Epilepsy/drug therapyEpilepsy/geneticsEpilepsy/physiopathologyEverolimusHumansImmunosuppressive Agents/pharmacologyNervous System Diseases/drug therapyNervous System Diseases/geneticsNervous System Diseases/physiopathologyProtein Kinases/drug effectsProtein Kinases/geneticsProtein Kinases/physiologySirolimus/analogs & derivativesSirolimus/pharmacologySirolimus/therapeutic useTOR Serine-Threonine KinasesTreatment OutcomeTuberous Sclerosis/geneticsTuberous Sclerosis/physiopathology
Substances： See more » Immunosuppressive AgentsEverolimusProtein KinasesMTOR protein, humanTOR Serine-Threonine KinasesSirolimus
Year: 2007 PMID： 17692052 DOI： 10.1111/j.1528-1167.2007.01178_2.x
Source DB: PubMed Journal: Epilepsia ISSN： 0013-9580 Impact factor: 5.864